BMRA Stock Analysis: Buy, Sell, or Hold?
BMRA - BIOMERICA INC
$2.41
0.16 (7.11%)
▲
5d:
+9.79%
30d:
+14.22%
90d:
+11.57%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 13, 2026
0d
Get Alerted When BMRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BMRA is 7.1% above its trading range ($2.25). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BMRA is 7.1% above its trading range ($2.25). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: BMRA is currently trading at $2.41, which is considered extended relative to its 30-day fair value range of $2.12 to $2.25.
Technical Outlook: Technically, BMRA is in a downtrend. The price is approaching resistance at $2.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.1% recently.
Market Sentiment: BMRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+439.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BMRA is in a downtrend. The price is approaching resistance at $2.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.1% recently.
Market Sentiment: BMRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+439.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.12 -
$2.25
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+7.1% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.1%)
- BULLISH: Trading 439.4% below Wall St target ($13.00)
- CAUTION: Extended 7.1% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$2.12 -
$2.25
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.14
Resistance Level
$2.44
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Wall Street Target
$13.00
(+439.4%)
Revenue Growth (YoY)
-11.8%
Profit Margin
-96.5%
Share & Embed Analysis
Last updated: May 14, 2026 6:39 PM ET
Data refreshes hourly during market hours. Next update: 7:39 PM
Data refreshes hourly during market hours. Next update: 7:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |
